{"id":11073,"date":"2020-09-28T19:07:46","date_gmt":"2020-09-28T10:07:46","guid":{"rendered":"http:\/\/aihara.la.coocan.jp\/?p=11073"},"modified":"2020-09-28T19:07:46","modified_gmt":"2020-09-28T10:07:46","slug":"%e3%82%b3%e3%83%ad%e3%83%8a%e3%82%a6%e3%82%a4%e3%83%ab%e3%82%b9%e6%84%9f%e6%9f%93%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%82%a4%e3%83%b3%e3%82%bf%e3%83%bc%e3%83%95%e3%82%a7%e3%83%ad%e3%83%b3%e7%94%a3","status":"publish","type":"post","link":"http:\/\/aihara.la.coocan.jp\/?p=11073","title":{"rendered":"\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u306b\u5bfe\u3059\u308b\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\u7523\u751f\u3092\u59a8\u3052\u308b\u907a\u4f1d\u5b50\u5909\u7570\u304c\u91cd\u75c7\u60a3\u8005\u3067\u591a\u3044"},"content":{"rendered":"<p>Biotoday\uff082020\/9\/28\uff09\u304b\u3089\uff1a<a href=\"https:\/\/www.biotoday.com\/view.cfm?n=92792\">https:\/\/www.biotoday.com\/view.cfm?n=92792<\/a><\/p>\n<p>\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30a6\u30a4\u30eb\u30b9\u3078\u306e1\u578b\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\uff081\u578bIFN\uff09\u514d\u75ab\u5fdc\u7b54\u306b\u643a\u308f\u308b\u3053\u3068\u304c\u77e5\u3089\u308c\u308b13\u907a\u4f1d\u5b50\u306e\u6050\u3089\u304f\u6a5f\u80fd\u640d\u5931\u5909\u7570\u304c\u91cd\u75c7\u306e\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\uff08SARS-CoV-2\uff09\u611f\u67d3\uff08COVID-19\uff09\u80ba\u708e\u5165\u9662\u60a3\u8005659\u4eba\u306b\u306f\u7121\u75c7\u72b6\uff5e\u8efd\u75c7\u611f\u67d3\u8005534\u4eba\u306b\u6bd4\u3079\u3066\u591a\u304f\u3001\u91cd\u75c7\u611f\u67d3\u8005\u306e\u5c11\u306a\u304f\u3068\u30823.5\uff05\uff0823\/659\u4eba\uff09\u306f\u305d\u308c\u308913\u907a\u4f1d\u5b50\u306e\u3044\u305a\u308c\u304b\u3092\u640d\u306a\u3063\u3066\u304a\u308a\u3001\u305d\u308c\u3089\u907a\u4f1d\u5b50\u6b20\u640d\u306fSARS-CoV-2\u3078\u306e1\u578bIFN\u751f\u6210\/\u53cd\u5fdc\u3092\u59a8\u3052\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<p>\u307e\u305f\u3001\u91cd\u75c7COVID-19\u80ba\u708e\u60a3\u8005987\u4eba\u306e\u7d0410\u4eba\u306b1\u4eba\uff0810\uff05\uff1b101\u4eba\uff09\u304c1\u578bIFN\uff08IFN-\u03c9\u3084IFN-\u03b1\uff09\u963b\u5bb3\uff08neutralizing\uff09\u81ea\u5df1\u6297\u4f53\u3092\u6709\u3057\u3066\u304a\u308a\u3001\u751f\u307e\u308c\u306a\u304c\u3089\u306e1\u578bIFN\u751f\u6210\u6b20\u640d\u3092\u6a21\u3059\u305d\u308c\u3089\u306e\u81ea\u5df1\u6297\u4f53\u306f1\u578bIFN\u306b\u3088\u308bSARS-CoV-2\u611f\u67d3\u963b\u6b62\u3092\u59a8\u3052\u308b\u3053\u3068\u304c\u7d30\u80de\u5b9f\u9a13\u3084\u611f\u67d3\u8005\u306e\u8840\u6f3f\u89e3\u6790\u3067\u793a\u5506\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<p>1\u578bIFN\u963b\u5bb3\u81ea\u5df1\u6297\u4f53\u304c\u8a8d\u3081\u3089\u308c\u305f101\u4eba\u306e\u6b86\u306995\u4eba\uff0894%\uff09\u306f\u7537\u6027\u3067\u3057\u305f\u3002<\/p>\n<p>\u5065\u5e38\u4eba1,227\u4eba\u306e\u81ea\u5df1\u6297\u4f53\u4fdd\u6709\u7387\u306f\u50c5\u304b0.33\uff05\uff084\/1227\u4eba\uff09\u3001\u7121\u75c7\u72b6\uff5e\u8efd\u75c7SARS-CoV-2\u611f\u67d3\u8005663\u4eba\u306b\u3044\u305f\u3063\u3066\u306f\u81ea\u5df1\u6297\u4f53\u306f\u8a8d\u3081\u3089\u308c\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/p>\n<p>\u4eca\u56de\u306e\u7d50\u679c\u306b\u3088\u308b\u3068\u7537\u6027\u3068\u5973\u6027\u306e\u91cd\u75c7COVID-19\u80ba\u708e\u306e\u305d\u308c\u305e\u308c\u5c11\u306a\u304f\u3068\u308213\uff05\u30683%\u304c1\u578bIFN\u963b\u5bb3\u81ea\u5df1\u6297\u4f53\u3092\u8981\u56e0\u3068\u3059\u308b\u3068\u8457\u8005\u306f\u8a00\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30102020\u5e749\u670828\u65e5\u8ffd\u8a18\u3011IFN\u306b\u81ea\u5df1\u6297\u4f53\u3092\u6709\u3059\u308b\u4eba\u3084IFN\u5fdc\u7b54\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u4eba\u306fCOVID-19\u306b\u5148\u7acb\u3063\u3066\u5165\u9662\u3092\u8981\u3059\u308b\u307b\u3069\u6df1\u523b\u306a\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306b\u9665\u3063\u305f\u7d4c\u9a13\u306f\u306a\u304f\u3001SARS-CoV-2\u3092\u9632\u3050\u306e\u306b\u6211\u3005\u306e\u4f53\u306f\u4ed6\u306e\u30a6\u30a4\u30eb\u30b9\u75be\u60a3\u4e88\u9632\u306b\u6bd4\u3079\u30661\u578bIFN\u3092\u3088\u308a\u983c\u308a\u306b\u3057\u3066\u3044\u308b\u3088\u3046\u3060\u3068\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5927\u5b66\u306e\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\u7814\u7a76\u514d\u75ab\u5b66\u8005Elina Zuniga\u6c0f\u306f\u8a00\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4eca\u56de\u306e2\u8a66\u9a13\u306e\u7d50\u679c\u306f\u56de\u5fa9\u8005\u304b\u3089\u306e\u8840\u6f3f\u306b\u3088\u308bCOVID-19\u6cbb\u7642\u306b\u5f71\u97ff\u3057\u307e\u3059\u3002\u56de\u5fa9\u8005\u304b\u3089\u306e\u8840\u6f3f\u306b\u306fIFN\u4e2d\u548c\u6297\u4f53\u304c\u542b\u307e\u308c\u3066\u3044\u308b\u6050\u308c\u304c\u3042\u308a\u3001\u6c17\u3065\u304b\u305a\u306b\u6295\u4e0e\u3057\u3066\u3057\u307e\u3046\u3053\u3068\u306f\u3042\u3063\u3066\u306f\u306a\u3089\u305a\u3001\u8840\u6f3f\u304b\u3089IFN\u4e2d\u548c\u6297\u4f53\u3092\u53d6\u308a\u9664\u304f\u624b\u7acb\u3066\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n<p>**************<br \/>\n\u56de\u5fa9\u671f\u306e\u8840\u6f3f\u306b\u95a2\u3059\u308b\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3068\u3057\u3066\u306f\u3001<br \/>\n\u25cf<a href=\"https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/\"><B>IDSA<\/B><\/a>\u306f<br \/>\n\u201dIDSA guideline panel recommends COVID-19 convalescent plasma only in the context of a clinical trial. (Knowledge gap)\u201d<\/p>\n<p>\u25cf<a href=\"https:\/\/app.magicapp.org\/#\/guideline\/4478\"><b>Australian guidelines for the clinical care of people with COVID-19<\/B><\/a>\u306f<br \/>\n\u201dFor people with COVID-19, do not use convalescent plasma outside of randomised trials with appropriate ethical approval.\u201d<\/p>\n<p>\u25cf<a href=\"https:\/\/lsp-sanford.jp\/sguide\/aaindex2.php\"><b>\u30b5\u30f3\u30d5\u30a9\u30fc\u30c9<\/b><\/a>\u3067\u306f<br \/>\n\u201d\u6709\u52b9\u6027\u306f\u8a3c\u660e\u3055\u308c\u3066\u3044\u306a\u3044\u201d<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotoday\uff082020\/9\/28\uff09\u304b\u3089\uff1ahttps:\/\/www.biotoday.com\/view.cfm?n=92792 \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30a6\u30a4\u30eb\u30b9\u3078\u306e1\u578b\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\uff081\u578bIFN\uff09\u514d\u75ab\u5fdc\u7b54\u306b\u643a\u308f\u308b\u3053\u3068\u304c\u77e5\u3089\u308c\u308b1 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[470],"tags":[],"_links":{"self":[{"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=\/wp\/v2\/posts\/11073"}],"collection":[{"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11073"}],"version-history":[{"count":6,"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=\/wp\/v2\/posts\/11073\/revisions"}],"predecessor-version":[{"id":11079,"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=\/wp\/v2\/posts\/11073\/revisions\/11079"}],"wp:attachment":[{"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11073"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/aihara.la.coocan.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}